Back
Editas Medicine 10K Form
Buy
54
EDIT
Editas Medicine
Last Price:
3.12
Seasonality Move:
16.26%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive EDIT News And Ratings
See the #1 stock for the next 7 days that we like better than EDIT
EDIT Financial Statistics
Sales & Book Value
| Annual Sales: | $78.12M |
|---|---|
| Cash Flow: | $-55.51M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.13 |
| Price / Book: | 1.47 |
Profitability
| EPS (TTM): | -2.56000 |
|---|---|
| Net Income (TTM): | $-210.57M |
| Gross Margin: | -- |
| Return on Equity: | -74.59% |
| Return on Assets: | -48.82% |
Editas Medicine Earnings Forecast
Key Editas Medicine Financial Ratios
- The Research & Development expenses have been 227.40% of Revenue.
- The Interest Expense is 5.47% of Operating Income.
- The Net Earning history of EDIT is -196.13% of Total Revenues.
- Per Share Earnings over the last 10 years have been positive in 4 years.
Editas Medicine Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | EDIT |
| CUSIP: | 28106W |
| Website: | editasmedicine.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.75 |
| Quick Ratio: | 3.67 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
EDIT Technical Analysis vs Fundamental Analysis
Buy
54
Editas Medicine (EDIT)
is a Buy
Is Editas Medicine a Buy or a Sell?
-
Editas Medicine stock is rated a Buy
The current Editas Medicine [EDIT] share price is $3.12. The Score for EDIT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.